CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $84,267,000 | -26.5% | 900 | -50.0% | 0.02% | -22.7% |
| Q1 2017 | $114,606,000 | -96.1% | 1,800 | -94.4% | 0.02% | -94.3% |
| Q3 2015 | $2,951,916,000 | -21.5% | 32,100 | -25.0% | 0.39% | -7.4% |
| Q2 2015 | $3,761,264,000 | +18.4% | 42,800 | 0.0% | 0.42% | +18.4% |
| Q1 2015 | $3,177,044,000 | +2366.6% | 42,800 | +1760.9% | 0.35% | +1976.5% |
| Q4 2014 | $128,800,000 | +23.5% | 2,300 | 0.0% | 0.02% | +13.3% |
| Q3 2014 | $104,328,000 | -47.5% | 2,300 | -52.1% | 0.02% | -44.4% |
| Q2 2014 | $198,768,000 | -46.4% | 4,800 | -10.3% | 0.03% | -47.1% |
| Q1 2014 | $370,595,000 | +14.9% | 5,350 | 0.0% | 0.05% | +4.1% |
| Q4 2013 | $322,445,000 | -0.8% | 5,350 | 0.0% | 0.05% | -7.5% |
| Q3 2013 | $325,173,000 | – | 5,350 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |